loading
Skip to main content
  • U.S. Department of Health & Human Services
National Institutes of Health (NIH) - Turning Discovery into Health

Research Methods Resources

Site Menu

  • Home
  • GRT
  • IRGT
  • GRT Sample Size Calculator
  • Glossary
  • References
  • FAQs
  • Feedback

The NIH has launched a series of initiatives to enhance the accountability and transparency of clinical research. These initiatives target key points along the entire clinical trial lifecycle, from concept to results reporting.

  • Expanded ClinicalTrials.gov registration and reporting policy covers all NIH-funded clinical trials, effective January 18, 2017.
  • New clinical trial requirements for NIH grants and contracts with due dates on or after January 25, 2018.
  • New application forms (FORMS-F) and application guide for all NIH research applications with due dates on or after May 25, 2020.
  • New review criteria for clinical trial applications with due dates on or after January 25, 2018.
  • New single IRB policy for research applications for multi-site studies with due dates on or after January 25, 2018.

The Research Methods Resources website provides investigators with important research methods resources to help them satisfy these new requirements. While the website currently only addresses methodological issues inherent in trials that randomize groups or deliver interventions to groups, new methods-related topics and resources will be added in the future. For a guided tour of this website, please refer to a Mind the Gap webinar, which presents additional information about its relevance to NIH requirements for clinical trials applications, a summary of the methodological issues inherent in nested study designs, and a demonstration of how to use the Group-Randomized Trials (GRT) Sample Size Calculator.

Trials that Randomize Groups or Deliver Interventions to Groups

Experiments, including clinical trials, differ considerably in the methods used to assign participants to study conditions (or study arms) and to deliver interventions to those participants. This website provides information related to the design and analysis of experiments in which 1) participants are assigned in groups (or clusters) OR participants are assigned individually but receive at least some of their intervention with other participants or through a change agent shared with other participants, and 2) individual observations are analyzed to evaluate the effect of the intervention. These studies may differ in their units of assignment (groups or clusters vs individuals), but they face the same expectation of positive correlation among observations taken on members who receive their intervention together, whether in pre-existing groups or in groups created by the investigator, and whether in person or through a common change agent.

The material is relevant for both human and animal studies and for both basic and applied research. And while it is important for investigators to become familiar with the issues presented on this website, it is even more important that they collaborate with a methodologist who is familiar with these issues.

Group- or cluster-randomized trials

Group or Cluster-Randomized Trials (GRTs)

In a group-randomized trial, also called a cluster-randomized trial, groups or clusters are randomized to study conditions, and observations are taken on the members of those groups.6, 17, 19, 23, 38 This design is common in public health, where the units of assignment may be schools, worksites, clinics, or whole communities, and the units of observation are the students, employees, patients, or residents within those groups. It is common in animal research, where the units of assignment may be litters of mice or rats and the units of observation are individual animals. It is also common in clinical research, where the units of assignment may be patients and the units of observation are individual teeth or eyes. Special methods are required for analysis and sample size estimation for these studies and investigators will need to show in their application that their methods are appropriate.
Learn more about the design and analysis of group- or cluster-randomized trials.

Individually randomized group-treatment trials

Individually Randomized Group-Treatment Trials (IRGTs)

In an individually randomized group-treatment trial, also called a partially clustered design, individuals are randomized to study conditions but receive at least some of their intervention with other participants or through a change agent shared with other participants.4, 5, 33-35, 45-47, 50, 51 This design is common in public health, where participants randomized to a weight-loss intervention may attend a class where they receive some of their intervention with other participants.31 It is common in psychology, where a therapist may treat multiple participants, either as a group or as individuals.3, 11, 53 Special methods are required for analysis and sample size estimation for these studies, and investigators will need to show that their methods are appropriate.
Learn more about the design and analysis of individually randomized group-treatment trials or partially clustered designs.

Questions? You may find answers on the Glossary and FAQs tabs.

Disclaimer. Substantial effort has been made to provide accurate and complete information on this website. However, we cannot guarantee that there will be no errors. Neither the U.S. Government nor the National Institutes of Health (NIH) assumes any legal liability for the accuracy, completeness, or usefulness of any information, products, or processes disclosed herein, or represents that use of such information, products, or processes would not infringe on privately owned rights. The NIH does not endorse or recommend any commercial products, processes, or services. The views and opinions of authors expressed on NIH websites do not necessarily state or reflect those of the U.S. Government, and they may not be used for advertising or product endorsement purposes.

This page was last updated/reviewed 3/27/2020

Footer

  • NIH Home
  • En Español
  • Site Map
  • Visitor Information
  • Frequently Asked Questions
  • Web Policies and Notices
  • Freedom of Information Act
  • No Fear Act
  • Office of Inspector General (link is external)
  • USA.gov – Government Made Easy (link is external)

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services (link is external)

Back to Top